IndraLab

Statements


| 9

reach
"In this in vitro system, doxycycline inhibited CSN5 catalyzed deneddylation with an IC 50 about 110 muM."

reach
"Thus, doxycycline selectively inhibits CSN5, instead of being a general inhibitor of the JAMM family, likely through a mechanism more than mere zinc chelation."

reach
"Doxycycline accumulates in DLBCL cells and inhibits CSN5 function in these cells."

reach
"The fact that doxycycline inhibited CSN5 activity significantly in vitro only at relatively high drug concentrations (IC 50 : ~ 110 muM) thus raised the question whether the concentrations of doxycycline in the DLBCL cells under our experimental conditions were sufficient to inhibit CSN5 activity."

reach
"To investigate whether doxycycline indeed inhibits the activity of CSN5 in DLBCL cells, we examined the effect of doxycycline treatment on cullin neddylation."

reach
"Doxycycline treatment resulted in an increase in the neddylated (slower migrating) forms of Cullin-1 and Cullin-2 in the DLBCL cells, indicating that doxycycline inhibits CSN5 activity in DLBCL cells."

reach
"Collectively, the results support the idea that doxycycline inhibits CSN5 function in cultured DLBCL cells."

reach
"Recent study showed that doxycycline selectively inhibited the deneddylase activity of Jab1/CSN5 in diffuse large B-cell lymphoma (DLBCL) cells."

reach
"Doxycycline inhibits CSN5 activity in vitro."